← Back to Search

Other

CO2 Laser Therapy for Peyronie's Disease

N/A
Waitlist Available
Led By Ryan Flannigan, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in penile measurements (baseline vs. week 18, 24, & 52).
Awards & highlights

Study Summary

This trial will study whether Fractional Carbon Dioxide Laser Therapy can help improve Peyronie's Disease.

Who is the study for?
This trial is for healthy males aged 18 or older, diagnosed with Peyronie's Disease for at least a year and have stable disease. They must be in a stable relationship, able to read and understand English, and willing to sign consent forms. Men with penile curvature between 30º-90º are eligible.Check my eligibility
What is being tested?
The study tests Fractional Carbon Dioxide Laser Therapy as a treatment for Peyronie's Disease. Participants will receive this therapy at a laser density coverage of 10-15%. It's designed to see if the laser can help reduce symptoms of the disease.See study design
What are the potential side effects?
Potential side effects may include discomfort during the procedure, redness, swelling, burning sensation on treated areas, changes in skin pigmentation, and scarring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in penile measurements (baseline vs. week 18, 24, & 52).
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in penile measurements (baseline vs. week 18, 24, & 52). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measured reduction in penile curvature
Secondary outcome measures
International Index of Erectile Function Questionnaire
Peyronie's Disease Questionnaire

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fractional CO2 Laser Therapy at 10-15% Laser Density CoverageExperimental Treatment1 Intervention
Study participants with Peyronies Disease will be treated with a Fractional Carbon Dioxide Laser set at a 10-15% laser density. The patient will receive three laser therapy sessions over 12 weeks (one session every four weeks). Following each session, topical triamcinolone will be applied to the treated area.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,467,006 Total Patients Enrolled
Ryan Flannigan, MDPrincipal InvestigatorUBC Faculty of Medicine - Department of Urologic Sciences
1 Previous Clinical Trials
12 Total Patients Enrolled

Media Library

Fractional Carbon Dioxide Laser Therapy (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04326465 — N/A
Peyronie's Disease Research Study Groups: Fractional CO2 Laser Therapy at 10-15% Laser Density Coverage
Peyronie's Disease Clinical Trial 2023: Fractional Carbon Dioxide Laser Therapy Highlights & Side Effects. Trial Name: NCT04326465 — N/A
Fractional Carbon Dioxide Laser Therapy (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04326465 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies still available to participate in this investigation?

"Evidently, this clinical trial is not recruiting patients any longer. It was first uploaded on May 1st 2021 and last modified on the 16th of May 2022 (according to information available on clinicialtrials.gov). However, 8 other trials are actively enrolling participants at present."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
How old are they?
18 - 65
What site did they apply to?
Diamond Health Care Centre
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease
Ryan Flannigan, MD 2021. "Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04326465.
All > Peyronies Disease
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top